NXGL NEXGEL, INC.

$0.59 -10.66%

Healthcare · Surgical & Medical Instruments & Apparatus

NEXGEL, INC. (NXGL) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $5 million. Shares last traded at $0.59, 79.1% below their 52-week high. Over the past year the stock is down 75.0%. Net profit margin is -26.3%, below the peer median of -7.6%. Revenue grew 31.5% year over year.

Market Cap

$5M

Shares Out

9.1M

EPS (TTM)

$-0.64

P/E Ratio

—

P/S Ratio

0.47

P/B Ratio

1.36

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.84

52-Week Low

$0.49

Volume

44,006

Avg Vol (3m)

5,256.524

Performance

-2.62%

+13.34%

-24.84%

-62.41%

YTD

-67.19%

-74.99%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.13

SMA (50)

$0.60

SMA (200)

$1.48

Price vs SMA50

-1.10%

Price vs SMA200

-60.01%

ATR (14)

$0.06

Financials

Revenue

$11M

Net Income

$-3M

Gross Margin

39.5%

Operating Margin

-29.3%

Net Margin

-26.3%

Return on Equity

-75.1%

Return on Assets

-25.9%

Current Ratio

1.70

Debt / Equity

0.14

Revenue Growth (YoY)

+31.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.11	2026-05-14
FY 2025	$-0.38	2026-03-31
Q3 2025	$-0.26	2025-11-12
Q2 2025	$-0.18	2025-08-12
Q1 2026	$-0.09	2026-05-14
FY 2025	$-0.50	2026-03-31

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

NXGL vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

0.47 / 2.52 med

-81% discount

Net margin vs peers

-26.3% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.